Abstract
We have recently described a new murine model of glioblastoma, generated by the implantation of syngeneic glioblastoma stem cells into immunocompetent mice, that recapitulates the salient histopathological and immunological features of the human disease. We employed this model to demonstrate the multifaceted activity of an oncolytic herpes simplex virus genetically modified to express interleukin-12, G47Δ-IL12.
Original language | English (US) |
---|---|
Article number | e27218 |
Journal | OncoImmunology |
Volume | 3 |
Issue number | 1 |
DOIs | |
State | Published - 2014 |
Externally published | Yes |
Keywords
- Cancer stem cells
- Glioma
- Herpes simplex virus
- Interleukin-12
- Oncolytic virus
- Treg